HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,999,908 | -3.9% | 55,815 | -8.6% | 0.01% | +14.3% |
| Q2 2023 | $5,200,351 | -0.4% | 61,080 | -3.2% | 0.01% | -12.5% |
| Q1 2023 | $5,222,353 | +2.3% | 63,110 | -2.8% | 0.01% | 0.0% |
| Q4 2022 | $5,106,273 | +7.5% | 64,924 | +1.2% | 0.01% | 0.0% |
| Q3 2022 | $4,751,000 | +11.4% | 64,179 | -1.9% | 0.01% | +14.3% |
| Q2 2022 | $4,266,000 | +3.7% | 65,448 | +0.5% | 0.01% | +40.0% |
| Q1 2022 | $4,115,000 | +9.9% | 65,096 | -7.8% | 0.01% | +25.0% |
| Q4 2021 | $3,746,000 | -23.1% | 70,629 | +2.3% | 0.00% | -33.3% |
| Q3 2021 | $4,872,000 | +5.2% | 69,016 | -0.7% | 0.01% | 0.0% |
| Q2 2021 | $4,632,000 | -53.6% | 69,512 | -22.7% | 0.01% | -53.8% |
| Q1 2021 | $9,989,000 | -6.1% | 89,979 | +0.4% | 0.01% | -13.3% |
| Q4 2020 | $10,639,000 | +39.0% | 89,595 | +2.2% | 0.02% | +25.0% |
| Q3 2020 | $7,652,000 | -0.2% | 87,697 | +2.4% | 0.01% | -14.3% |
| Q2 2020 | $7,668,000 | +0.2% | 85,614 | +11.5% | 0.01% | -12.5% |
| Q1 2020 | $7,651,000 | -14.9% | 76,770 | -1.9% | 0.02% | +6.7% |
| Q4 2019 | $8,990,000 | -10.7% | 78,238 | -2.0% | 0.02% | -25.0% |
| Q3 2019 | $10,068,000 | +6.1% | 79,819 | +1.2% | 0.02% | +5.3% |
| Q2 2019 | $9,491,000 | +38.2% | 78,865 | +0.4% | 0.02% | +35.7% |
| Q1 2019 | $6,869,000 | -15.7% | 78,519 | -3.5% | 0.01% | -26.3% |
| Q4 2018 | $8,145,000 | -10.6% | 81,407 | +2.4% | 0.02% | +5.6% |
| Q3 2018 | $9,110,000 | +23.5% | 79,508 | -3.3% | 0.02% | +20.0% |
| Q2 2018 | $7,375,000 | +22.9% | 82,237 | +0.2% | 0.02% | +15.4% |
| Q1 2018 | $6,002,000 | +23.1% | 82,037 | -2.2% | 0.01% | +30.0% |
| Q4 2017 | $4,874,000 | +29.5% | 83,913 | +0.0% | 0.01% | +25.0% |
| Q3 2017 | $3,765,000 | +2.6% | 83,898 | -9.7% | 0.01% | 0.0% |
| Q2 2017 | $3,668,000 | -10.3% | 92,891 | -7.9% | 0.01% | 0.0% |
| Q1 2017 | $4,090,000 | -3.6% | 100,812 | -4.5% | 0.01% | -11.1% |
| Q4 2016 | $4,242,000 | +8.0% | 105,512 | -2.7% | 0.01% | +12.5% |
| Q3 2016 | $3,926,000 | +26.2% | 108,412 | +1.0% | 0.01% | +14.3% |
| Q2 2016 | $3,111,000 | -19.0% | 107,312 | -2.2% | 0.01% | -12.5% |
| Q1 2016 | $3,840,000 | +24.4% | 109,768 | +14.7% | 0.01% | 0.0% |
| Q4 2015 | $3,086,000 | +1.2% | 95,732 | +1.5% | 0.01% | 0.0% |
| Q3 2015 | $3,048,000 | -21.9% | 94,292 | -0.1% | 0.01% | -11.1% |
| Q2 2015 | $3,904,000 | -8.7% | 94,392 | -0.9% | 0.01% | -10.0% |
| Q1 2015 | $4,277,000 | +18.1% | 95,220 | -1.7% | 0.01% | +25.0% |
| Q4 2014 | $3,623,000 | +8.0% | 96,820 | +0.7% | 0.01% | 0.0% |
| Q3 2014 | $3,356,000 | +0.1% | 96,109 | +1.1% | 0.01% | 0.0% |
| Q2 2014 | $3,354,000 | +10.8% | 95,063 | +2.4% | 0.01% | 0.0% |
| Q1 2014 | $3,026,000 | -22.3% | 92,863 | +0.4% | 0.01% | -27.3% |
| Q4 2013 | $3,895,000 | +6.3% | 92,463 | +0.7% | 0.01% | 0.0% |
| Q3 2013 | $3,663,000 | -0.5% | 91,863 | +3.2% | 0.01% | -8.3% |
| Q2 2013 | $3,680,000 | +0.3% | 89,006 | +1.1% | 0.01% | 0.0% |
| Q1 2013 | $3,668,000 | – | 88,058 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |